LipoPeptide Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A

LipoPeptide General Information

Description

Developer of biopharmaceutical products for wound care. The company develops lipopeptide-based products for the treatment of wounds, including chronic, non-healing ulcers in skin and mucous membranes.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Pharmaceuticals
Other Industries
Biotechnology
Primary Office
  • Karolinska Institutet Science Park
  • Fogdevreten 2a
  • 171 65 Solna
  • Sweden
+46 08-524 000 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

LipoPeptide Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 31-Dec-2010 Completed Startup
2. Merger/Acquisition Completed Startup
1. Early Stage VC Completed Startup
To view LipoPeptide’s complete valuation and funding history, request access »

LipoPeptide Executive Team (1)

Name Title Board Seat Contact Info
Fredrik Sjövall Managing Director
To view LipoPeptide’s complete executive team members history, request access »

LipoPeptide Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Midroc Invest Venture Capital Minority 000 0000 000000 0
To view LipoPeptide’s complete investors history, request access »